Comparison of accelerator based radioisotope production potentials in medical imaging

Yıl 2020, Cilt: 41 Sayı: 1, 152 - 159, 22.03.2020

Şeyda Akçay Sinan Kuday

https://doi.org/10.17776/csj.621600

Öz

Most recent production capabilities of highly demanded radoisotopes in
medical diagnosis and imaging is not as high as the increasing number of
patients worldwide. We studied radioisotope production efficiencies of ^99m Tc, ¹¹¹In,
¹⁸F, ¹¹C, ^125,124I, ⁶⁷Ga, ⁶⁴Cu
ve ⁸⁶Y at medical accelerators through hadronic collision
simulations by Geant4. We considered to recent production parameters and
calculated the optimal values for parameters such as Q-value, cross section,
production energy and irradiation yields. This study also aimed to shed light
on the radionuclide production in the region. 

Anahtar Kelimeler

Geant4, ROOT, Radioisotope, Simulation

Kaynakça

• [1] Smith N.B., Webb A., Nuclear medicine: planar scintigraphy, SPECT and PET/CT. Introduction to Medical Imaging: Physics, Engineering and Clinical Applications. 1st ed. Cambridge University Press the Edinburgh Building; (2011), 89-139.
• [2] Gündoğdu E., Özgenç E., Ekinci M., İlem Özdemir D., Aşıkoğlu M., Radiopharmaceuticals Used in Imaging and Treatment in Nuclear Medicine, Journal of Literature Pharmacy Sciences, 7(1) (2018) 24-34.
• [3] Patient Care, What is Nuclear Medicine, What is PET/CT ? What are the benefits of Nuclear Medicine Adress: http://med.stanford.edu/nuclearmedicine/patient_care.html Retrieved Sept. 18 2019.
• [4] Demir M., Nükleer Tıp Fiziği ve Klinik Uygulamaları, İstanbul Üniversitesi Tıp Fakültesi Yayınları, 4. Baskı, (2014).
• [5] Teksöz S., Müftüler F.Z.B., Radioisotopes and Biomedical Applications in Nuclear Medicine, Nucl Med Seminerleri 5 (2019) 10-14.
• [6] What is a radiopharmaceutical? Adress: https://www.insideradiology.com.au/nuclear-medicine/ Retrieved Sept. 18 (2019).
• [7] Ertay T.,Infection-Inflammation: SPECT Radiopharmaceuticals for Molecular Imaging/Enfeksiyon-Enflamasyon: Molekuler Goruntulemede Kullanilan SPECT Radyofarmasotikleri., Nuclear Medicine Seminars, 2(2) (2016) 63+. Gale Academic OneFile, Accessed Sept. 18 2020.
• [8] Frederic H. Fahey et. al., Nuclear Medicine and Radiation Protection, Journal of Radiology Nursing, 35(1) (2016).
• [9] Akdemir Ü.Ö., Karabacak N.İ., Atay L.Ö., Positron Emission Tomography/Magnetic Resonanse Imaging Applications in Neurologic Imaging, Nuclear Medicine Seminars 1 (2017) 52-58.
• [10] About Imaging Agents Or Tracers, Adress: https://www.acrin.org/PATIENTS/ABOUTIMAGINGEXAMSANDAGENTS/ABOUTIMAGINGAGENTSORTRACERS.aspx Retrieved Sept. 18 2019.
• [11] E. Özdemir, D. Bedel, Advances in Nuclear Cardiology: Instrumentation, Software and Radiopharmaceuticals, Nucl. Med. Semin. 4 (2018) 145-156.
• [12] Ocak M., Radiopharmaceuticals for PET, Toraks Cerrahisi Bülteni 6 (2015) 154-160.
• [13] R. Brun and F. Rademakers, ROOT - An Object Oriented Data Analysis Framework, Proceedings AIHENP'96 Workshop, Lausanne, Sep. 1996, Nucl. Inst. & Meth. in Phys. Res. A 389 (1997) 81-88.